FedTALLY

Awards for “NOVARTIS PHARMACEUTICALS CORPORATION

25 awards on this page · sorted by amount · page 1

Award IDRecipientAwarding agencyAmountStartEndNAICSDescription
HHSO100201700026CNOVARTIS PHARMACEUTICALS CORPORATIONDepartment of Health and Human Services$16.33M
2017-09-142026-05-22541711ELTROMBOPAG: A MEDICAL COUNTERMEASURE TO MITIGATE THROMBOCYTOPENIA FOLLOWING MYELOSUPPRESSIVE DOSES OF RADIATIONSEE STATEMENT OF WORK FOR MORE DETAILSIGF::OT::IGF
36C24826F0082NOVARTIS PHARMACEUTICALS CORPORATIONDepartment of Veterans Affairs$4.73M
2026-02-242026-08-31325412PLUVICTO
36C25726N0205NOVARTIS PHARMACEUTICALS CORPORATIONDepartment of Veterans Affairs$4.16M
2026-02-072027-02-06325412LU177 - PLUVICTO/LUTATHERA
36C26126F0007NOVARTIS PHARMACEUTICALS CORPORATIONDepartment of Veterans Affairs$3.99M
2025-10-012026-09-30325412PLUVICTO DRUG
36C26226N0112NOVARTIS PHARMACEUTICALS CORPORATIONDepartment of Veterans Affairs$3.91M
2025-11-012026-10-31325412PLUVICTO AND LUTATHERA
W81K0024F0177NOVARTIS PHARMACEUTICALS CORPORATIONDepartment of Defense$3.39M
2024-10-012025-09-30325412DELIVERY ORDER FOR PLUVICTO AND LUTATHERA
W81K0025FA195NOVARTIS PHARMACEUTICALS CORPORATIONDepartment of Defense$3.23M
2025-10-012026-09-30325412LUTATHERA AND PLUVICTO
36C25725N0190NOVARTIS PHARMACEUTICALS CORPORATIONDepartment of Veterans Affairs$2.67M
2025-02-072026-02-06325412LUTATHERA & PLUVICTO
36C25026N0310NOVARTIS PHARMACEUTICALS CORPORATIONDepartment of Veterans Affairs$2.42M
2026-02-012026-12-31325412RADIOPHARMACEUTICALS PLUVICTO / LUTATHERA
36C24426F0063NOVARTIS PHARMACEUTICALS CORPORATIONDepartment of Veterans Affairs$1.98M
2026-01-012026-12-31325412RADIOPHARMACEUTICALS-LUTATHERA AND PLUVICTO INJECTIONS
36C26126F0017NOVARTIS PHARMACEUTICALS CORPORATIONDepartment of Veterans Affairs$1.63M
2025-10-012026-09-30325412PLUVICTO FY26
36C25026N0006NOVARTIS PHARMACEUTICALS CORPORATIONDepartment of Veterans Affairs$1.16M
2025-10-012026-09-30325412PLUVICTO
36C26126F0168NOVARTIS PHARMACEUTICALS CORPORATIONDepartment of Veterans Affairs$1.03M
2026-04-012026-09-30325412PLUVICTO - LUTETIUM LU 177 VIPIVOTIDE TETRA 27MCI/ML
36C26226F0048NOVARTIS PHARMACEUTICALS CORPORATIONDepartment of Veterans Affairs$1.02M
2026-01-022027-01-01325412PLUVICTO (LUTETIUM LU 177 VIPIVOTIDE TETRA 27MCI/ML)
36C25225F0191NOVARTIS PHARMACEUTICALS CORPORATIONDepartment of Veterans Affairs$1.01M
2025-09-012026-08-31325412DELIVERY ORDER FOR A BASE PLUS ONE (1) OPTION YEAR FOR THE RADIOPHARMACEUTICAL PLUVICTO.
36C25725N0376NOVARTIS PHARMACEUTICALS CORPORATIONDepartment of Veterans Affairs$857.36K
2025-07-012027-06-30325412PLUVICTO
36C26226F0314NOVARTIS PHARMACEUTICALS CORPORATIONDepartment of Veterans Affairs$823.06K
2026-07-202026-12-31325412PLUVICTO DELIVERY ORDER
36C25226N0246NOVARTIS PHARMACEUTICALS CORPORATIONDepartment of Veterans Affairs$823.06K
2026-02-012026-09-30325412PLUVICTO
36C24226N0216NOVARTIS PHARMACEUTICALS CORPORATIONDepartment of Veterans Affairs$813.48K
2025-11-012026-10-31325412PLUVICTO (LUTETIUM LU 177 VIPIVOTIDE TETRA 27MCI/ML)
36C24125F0148NOVARTIS PHARMACEUTICALS CORPORATIONDepartment of Veterans Affairs$810.28K
2025-09-152026-09-14325412PLUVICTO
36C25525N0396NOVARTIS PHARMACEUTICALS CORPORATIONDepartment of Veterans Affairs$736.61K
2025-08-052026-08-04325412PLUVICTO
36C26126F0008NOVARTIS PHARMACEUTICALS CORPORATIONDepartment of Veterans Affairs$679.95K
2025-10-012026-09-30325412LUTATHERA CANCER THERAPY
36C25026N0416NOVARTIS PHARMACEUTICALS CORPORATIONDepartment of Veterans Affairs$617.3K
2026-07-012026-12-3132541226AP2812 - PLUVICTO - CLEVELAND VAMC
36C25026F0205NOVARTIS PHARMACEUTICALS CORPORATIONDepartment of Veterans Affairs$617.3K
2026-01-202026-06-30325412PLUVICTO 2026 - CLEVELAND VAMC
36C25025F0384NOVARTIS PHARMACEUTICALS CORPORATIONDepartment of Veterans Affairs$598.12K
2025-02-052025-08-31325412PLUVICTO RADIO PHARMA 2025 - CLEVELAND VAMC